Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Dark Plum Pill for Prevention of Colorectal Adenoma Recurrence After Endoscopic Treatment
ChiCTR-IIR-16008902Phase 2Recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Jan 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Jiajian Wumei Wan in colon adenoma (2 arms), sponsored by Beijing University of Chinese Medicine. Primary endpoint: occurrence rate of colorectal adenoma. Started Jan 2016; status: recruiting.
02
Drugs
Jiajian Wumei Wan
03
Conditions
colon adenoma
Beyond the preview
Go deeper on ChiCTR-IIR-16008902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16008902.